Latest filing published 05 Jan 2024 for Kronos Bio, Inc., €13k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jorge DiMartino: trading record in brief
Jorge DiMartino, listed as senior executive, appears in our data through filings on Kronos Bio, Inc. shares, published by SEC (Form 4). In total, 11 filings cover trades dated from 9 December 2020 to 4 January 2024.
Sales make up the whole of the open-market record (7 sales, €279k). Other entries cover 4 share grants. So far in 2024, the count stands at no purchases and 1 sale.
Most recently, on 5 January 2024, the filings show an open-market sale worth €13k in Kronos Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jorge DiMartino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,009 shares@ US$1.18362.9% of flowCommon StockSEC:0001209191-24-001066:0
- 17,367 shares@ US$1.3054.6% of flowCommon StockSEC:0001209191-23-058464:0
- 10,818 shares@ US$1.75233.8% of flowCommon StockSEC:0001209191-23-041787:0
- 10,153 shares@ US$1.73553.7% of flowCommon StockSEC:0001209191-23-013016:0
- 137,008 shares0Common StockSEC:0001209191-23-010586:0
- 18,657 shares@ US$1.80527.1% of flowCommon StockSEC:0001209191-22-061222:0
- 60,300 shares0Common StockSEC:0001209191-22-043285:0
- 60,300 shares0Common StockSEC:0001209191-22-010904:0
- 16,152 shares@ US$12.36363.8% of flowCommon StockSEC:0001209191-21-069781:0
9 of 9 declarations
